Your browser doesn't support javascript.
loading
Programmatic management of rifampicin-resistant tuberculosis with standard regimen in Cameroon: a retrospective cohort study.
Jouego, Christelle Géneviève; Gils, Tinne; Piubello, Alberto; Mbassa, Vincent; Kuate, Albert; Ngono, Annie; Belinga, Edwige; Etoundi, Antoine; Tollo, Alphonse; Makondi, Danielle; André, Emmanuel; Masumbe, Palmer; Lynen, Lutgarde; Noeske, Jürgen; Decroo, Tom.
Afiliação
  • Jouego CG; Cameroon National Tuberculosis Program (NTP), Mballa 2, BP 15 656 Yaoundé, Cameroun; Institute of Tropical Medicine, Department of Clinical Sciences, Unit of HIV and Tuberculosis, Nationalestraat 155, 2000 Antwerp, Belgium; University of Yaoundé 1, Biotechnology centre, Molecular Diagnostic and Rese
  • Gils T; Institute of Tropical Medicine, Department of Clinical Sciences, Unit of HIV and Tuberculosis, Nationalestraat 155, 2000 Antwerp, Belgium. Electronic address: tgils@itg.be.
  • Piubello A; Damien Foundation, Boulevard Leopold II 263, 1081 Koekelberg, Brussels, Belgium.
  • Mbassa V; Cameroon National Tuberculosis Program (NTP), Mballa 2, BP 15 656 Yaoundé, Cameroun.
  • Kuate A; Cameroon National Tuberculosis Program (NTP), Mballa 2, BP 15 656 Yaoundé, Cameroun.
  • Ngono A; Cameroon National Tuberculosis Program (NTP), Mballa 2, BP 15 656 Yaoundé, Cameroun. Electronic address: anniebissongono@pnlt.cm.
  • Belinga E; Cameroon National Tuberculosis Program (NTP), Mballa 2, BP 15 656 Yaoundé, Cameroun. Electronic address: abengmvondo@pnlt.cm.
  • Etoundi A; Cameroon National Tuberculosis Program (NTP), Mballa 2, BP 15 656 Yaoundé, Cameroun. Electronic address: antoineetoundi@pnlt.cm.
  • Tollo A; Cameroon National Tuberculosis Program (NTP), Mballa 2, BP 15 656 Yaoundé, Cameroun. Electronic address: albertkuate@pnlt.cm.
  • Makondi D; Cameroon National Tuberculosis Program (NTP), Mballa 2, BP 15 656 Yaoundé, Cameroun. Electronic address: danieltollo@pnlt.cm.
  • André E; Catholic University of Leuven, Laboratory of Clinical Microbiology, Department of Microbiology, Immunology and Transplantation, UZ Herestraat 49, 3000 Leuven, Belgium. Electronic address: emmanuel.andre@uzleuven.be.
  • Masumbe P; University of Yaoundé 1, Biotechnology centre, Molecular Diagnostic and Research Group, 11864 Yaoundé, Cameroon. Electronic address: masumbe.palmer@facsciences-uy1.cm.
  • Lynen L; Institute of Tropical Medicine, Department of Clinical Sciences, Unit of HIV and Tuberculosis, Nationalestraat 155, 2000 Antwerp, Belgium. Electronic address: llynen@itg.be.
  • Noeske J; Independent Consultant, Yaoundé, Cameroon.
  • Decroo T; Institute of Tropical Medicine, Department of Clinical Sciences, Unit of HIV and Tuberculosis, Nationalestraat 155, 2000 Antwerp, Belgium; Research Foundation Flanders, Egmontstraat 5, 1000 Brussels, Belgium. Electronic address: tdecroo@itg.be.
Int J Infect Dis ; 124: 81-88, 2022 Nov.
Article em En | MEDLINE | ID: mdl-36108960
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Tuberculose Resistente a Múltiplos Medicamentos Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans / Male País/Região como assunto: Africa Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Tuberculose Resistente a Múltiplos Medicamentos Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans / Male País/Região como assunto: Africa Idioma: En Ano de publicação: 2022 Tipo de documento: Article